Double-blind and open studies of lithium prophylaxis in affective disorders
There is now abundant evidence that the morbidity of recurrent affective disorders continues to be high even when treated by the best conventional methods. Continuous lithium treatment has now been shown to considerably reduce the morbidity of both unipolar recurrent depressive patients and both the manic and depressive phase of the bipolar patients.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.